Cholestatic hepatocellular injury: what do we know and how should we proceed
Authors:
- Gregory J. GoresGGGregory J. Gores
- 1 March 2005
- journal article
- editorial
- Published by Elsevier in Journal of Hepatology
- Vol. 42 (3) , 297-300
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout miceGastroenterology, 2004
- Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasisJournal of Clinical Investigation, 2003
- Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated miceGastroenterology, 2003
- 6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic ActivityJournal of Medicinal Chemistry, 2002
- Bile Salt TransportersAnnual Review of Physiology, 2002
- BSEP: Function and Role in Progressive Familial Intrahepatic CholestasisSeminars in Liver Disease, 2001
- Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasisGastroenterology, 2000
- Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasisGastroenterology, 1999
- A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasisNature Genetics, 1998
- Hepatic injury induced by bile salts: Correlation between biochemical and morphological eventsHepatology, 1990